DTC
INO icon

Deep Track Capital’s Inovio Pharmaceuticals INO Stock Holding History

Deep Track Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,981,370
Closed -$4.03M – 61
2025
Q2 		$4.03M Sell
1,981,370
-1,137,792
-36% -$2.18M 0.13% 56
2025
Q1 		$5.08M Hold
3,119,162
– – 0.16% 59
2024
Q4 		$5.71M Buy
3,119,162
+1,314,796
+73% +$5.82M 0.21% 55
2024
Q3 		$10.4M Sell
1,804,366
-262,354
-13% -$2.16M 0.33% 57
2024
Q2 		$16.7M Buy
+2,066,720
New +$21.7M 0.5% 46

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deep Track Capital's INO Position: Q3 2025 in Review

Deep Track Capital sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 1,981,370 shares — an estimated $4.03M sold.

Deep Track Capital first reported a position in INO in Q2 2024 and held it in 5 quarters. The position peaked at $16.7M in Q2 2024. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • Deep Track Capital reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Deep Track Capital sold 1,981,370 Inovio Pharmaceuticals shares in Q3 2025, an estimated $4.03M.
  • Deep Track Capital first reported a position in Inovio Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Deep Track Capital's Inovio Pharmaceuticals position peaked at $16.7M in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on Deep Track Capital's 13F filing for Q3 2025, filed 14 Nov 2025.